• Bharat Parenterals schedules board meeting on May 18, 2026 to approve FY26 financial results and dividend.
• Board will consider audited standalone and consolidated results for quarter and year ended March 31, 2026.
• Meeting agenda includes recommendation of final dividend for FY26, subject to board approval.
• Trading window closed since April 1, 2026 and will reopen 48 hours after results declaration.